BDX is starting its breast cancer blood test AUS and USA roll out soon and according to yesterday's presentation they are going a similar way that IPD is going atm. They unlikely use the same advisors, that way IPD's current approach should be the right one. It just takes time and some bureaucrats to understand that besides assisting early detection the hospitals actually can make a few coins with every test as well. Sometimes a smack on the head is needed to turn on some decision maker's brain. Too many have theirs' active from 12pm to Noon only.
GLTA
IPD Price at posting:
5.5¢ Sentiment: Buy Disclosure: Held
